Zyversa Therapeutics Stock Probability of Future Stock Price Finishing Over 20.0
| ZVSA Stock | 0.15 0.02 11.76% |
ZyVersa Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ZyVersa Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ZyVersa Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ZyVersa Therapeutics is way too risky over 90 days horizon | |
| ZyVersa Therapeutics has some characteristics of a very speculative penny stock | |
| ZyVersa Therapeutics appears to be risky and price may revert if volatility continues | |
| ZyVersa Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.41 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ZyVersa Therapeutics generates negative cash flow from operations |
ZyVersa Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ZyVersa Stock often depends not only on the future outlook of the current and potential ZyVersa Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ZyVersa Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 1.5 M |
ZyVersa Therapeutics Technical Analysis
ZyVersa Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. ZyVersa Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ZyVersa Therapeutics. In general, you should focus on analyzing ZyVersa Stock price patterns and their correlations with different microeconomic environments and drivers.
ZyVersa Therapeutics Predictive Forecast Models
ZyVersa Therapeutics' time-series forecasting models is one of many ZyVersa Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ZyVersa Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ZyVersa Therapeutics
Checking the ongoing alerts about ZyVersa Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ZyVersa Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ZyVersa Therapeutics is way too risky over 90 days horizon | |
| ZyVersa Therapeutics has some characteristics of a very speculative penny stock | |
| ZyVersa Therapeutics appears to be risky and price may revert if volatility continues | |
| ZyVersa Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.41 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ZyVersa Therapeutics generates negative cash flow from operations |
Check out ZyVersa Therapeutics Backtesting, ZyVersa Therapeutics Valuation, ZyVersa Therapeutics Correlation, ZyVersa Therapeutics Hype Analysis, ZyVersa Therapeutics Volatility, ZyVersa Therapeutics History as well as ZyVersa Therapeutics Performance. For information on how to trade ZyVersa Stock refer to our How to Trade ZyVersa Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ZyVersa Therapeutics. If investors know ZyVersa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ZyVersa Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ZyVersa Therapeutics is measured differently than its book value, which is the value of ZyVersa that is recorded on the company's balance sheet. Investors also form their own opinion of ZyVersa Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ZyVersa Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ZyVersa Therapeutics' market value can be influenced by many factors that don't directly affect ZyVersa Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ZyVersa Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ZyVersa Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ZyVersa Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.